Key result
Document contains only journal editorial board information and no clinical study data.
Why the study?
What are the values and preferences of patients with atrial fibrillation regarding antithrombotic therapy for stroke prevention?
Population
Patients with atrial fibrillation (25 studies included)
Design
Systematic_review
Authors
Loading...
Heterogeneous AF patient preferences for antithrombotic therapy support individualized shared decision-making; extends evidence for patient-centered guidelines.
What are the values and preferences of patients with atrial fibrillation regarding antithrombotic therapy for stroke prevention?
Patients' values and preferences for stroke prevention therapy in atrial fibrillation are highly heterogeneous, emphasizing the need for individualized clarification and shared decision-making.
Loewen et al. (2017) studied this question. The provided text contains only journal editorial board information and no clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: